Comparative analysis of Access PCT and Elecsys BRAHMS PCT assays for procalcitonin measurements

Background Procalcitonin (PCT) is a crucial biomarker for diagnosing sepsis and managing antibiotic therapy. This study evaluated the analytical performance and comparability of the Access PCT and Elecsys BRAHMS PCT assays. Methods The precision, detection capability, linearity, and reference range...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyunji Choi, Sang-Shin Lee, Hyunyong Hwang
Format: Article
Language:English
Published: Kosin University College of Medicine 2024-12-01
Series:Kosin Medical Journal
Subjects:
Online Access:http://www.kosinmedj.org/upload/pdf/kmj-24-155.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Procalcitonin (PCT) is a crucial biomarker for diagnosing sepsis and managing antibiotic therapy. This study evaluated the analytical performance and comparability of the Access PCT and Elecsys BRAHMS PCT assays. Methods The precision, detection capability, linearity, and reference range of both assays were assessed. A comparative analysis included 182 patient samples categorized into four risk groups to compare the results between Access PCT and Elecsys BRAHMS PCT assays. Results The Access PCT assay demonstrated precision within the manufacturer’s threshold, and its detection capabilities were verified. This assay exhibited excellent linearity and appropriate reference intervals. Comparative analysis indicated that the Access PCT assay reported higher overall PCT levels than the Elecsys BRAHMS assay, with high agreement between the assays (κ=0.941). However, the biases varied across different PCT concentration intervals. Conclusions Both the Access PCT and Elecsys BRAHMS PCT assays performed robustly with notable concordance but varying biases at different concentration intervals. The observed biases require careful consideration in clinical decision-making, especially when adopting novel assay systems. Standardizing the calibration across different platforms is recommended to improve assay comparability.
ISSN:2005-9531
2586-7024